Acarbose
NDC 0054-0140, Acarbose, tablet, from Hikma Pharmaceuticals USA Inc..
- Product NDC
- 0054-0140
- Status
- Listed
- Labeler
- Hikma Pharmaceuticals USA Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA078470
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0054-0140 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ACARBOSE25 mg/1
Pharmacologic classes
alpha Glucosidase Inhibitors [MoA]; alpha-Glucosidase Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0054-0140-25 | 00054014025 | 100 TABLET in 1 BOTTLE (0054-0140-25) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/352dd336-d3f9-4ac5-a000-91d3aef7aca3NADAC price for package 00054014025
GET /v1/drugs/nadac/00054014025
Use it
Look up 0054-0140 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0054-0140 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0054-0140. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.